Multiple Myeloma (MM)
Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

Multiple Myleoma Related Probes

ON MM 11q23 / DLEU (13q14) red/green KBI-10502
ON MM 1q21 / 8p21 red/green KBI-10503
ON MM 15q22 / 6q21 red/green KBI-10504
ON MM 1q21 / SRD (1p36) red/green KBI-10507
ON MM 15q22 / 9q34 red/green KBI-10508
ON MM 19q13 / p53 (17p13) red/green KBI-10509

 

Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

Multiple Myleoma Related Probes

ON MM 11q23 / DLEU (13q14) red/green KBI-10502
ON MM 1q21 / 8p21 red/green KBI-10503
ON MM 15q22 / 6q21 red/green KBI-10504
ON MM 1q21 / SRD (1p36) red/green KBI-10507
ON MM 15q22 / 9q34 red/green KBI-10508
ON MM 19q13 / p53 (17p13) red/green KBI-10509

 

   
Multiple Myeloma (MM)

The cytogenetic picture in multiple myeloma (MM) is highly complex, from which non-random numerical and structural chromosomal changes have been identified. Specifically, translocations involving the immunoglobulin heavy chain gene (IGH) at 14q32 and either monosomy or deletions of chromosome 13 have been observed in a significant number of patients. More recently several additional deletions or amplifications have been identified in MM which are currently investigated in large patient studies.

Note: Multiple Myeloma is a cancer of plasma cells. Analysis of such cells is hampered by their low frequency. Enrichment of plasma cells using CD138 is highly recommended.

The cytogenetic picture in multiple myeloma (MM) is highly complex, from which non-random numerical and structural chromosomal changes have been identified. Specifically, translocations involving the immunoglobulin heavy chain gene (IGH) at 14q32 and either monosomy or deletions of chromosome 13 have been observed in a significant number of patients. More recently several additional deletions or amplifications have been identified in MM which are currently investigated in large patient studies.

Note: Multiple Myeloma is a cancer of plasma cells. Analysis of such cells is hampered by their low frequency. Enrichment of plasma cells using CD138 is highly recommended.